Biodefense-China Market Status and Trend Report 2013-2023
Report Summary
Biodefense-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biodefense industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole China and Regional Market Size of Biodefense 2013-2017, and development forecast 2018-2023
Main market players of Biodefense in China, with company and product introduction, position in the Biodefense market
Market status and development trend of Biodefense by types and applications
Cost and profit status of Biodefense, and marketing status
Market growth drivers and challenges
The report segments the China Biodefense market as:
China Biodefense Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North China
Northeast China
East China
Central & South China
Southwest China
Northwest China
China Biodefense Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Anthrax
Smallpox
Botulism
Radiation/Nuclear
China Biodefense Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Industry
Chemical
China Biodefense Market: Players Segment Analysis (Company and Product introduction, Biodefense Sales Volume, Revenue, Price and Gross Margin):
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Biodefense-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biodefense industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole China and Regional Market Size of Biodefense 2013-2017, and development forecast 2018-2023
Main market players of Biodefense in China, with company and product introduction, position in the Biodefense market
Market status and development trend of Biodefense by types and applications
Cost and profit status of Biodefense, and marketing status
Market growth drivers and challenges
The report segments the China Biodefense market as:
China Biodefense Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North China
Northeast China
East China
Central & South China
Southwest China
Northwest China
China Biodefense Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Anthrax
Smallpox
Botulism
Radiation/Nuclear
China Biodefense Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Industry
Chemical
China Biodefense Market: Players Segment Analysis (Company and Product introduction, Biodefense Sales Volume, Revenue, Price and Gross Margin):
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BIODEFENSE
1.1 Definition of Biodefense in This Report
1.2 Commercial Types of Biodefense
1.2.1 Anthrax
1.2.2 Smallpox
1.2.3 Botulism
1.2.4 Radiation/Nuclear
1.3 Downstream Application of Biodefense
1.3.1 Industry
1.3.2 Chemical
1.4 Development History of Biodefense
1.5 Market Status and Trend of Biodefense 2013-2023
1.5.1 China Biodefense Market Status and Trend 2013-2023
1.5.2 Regional Biodefense Market Status and Trend 2013-2023
CHAPTER 2 CHINA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Biodefense in China 2013-2017
2.2 Consumption Market of Biodefense in China by Regions
2.2.1 Consumption Volume of Biodefense in China by Regions
2.2.2 Revenue of Biodefense in China by Regions
2.3 Market Analysis of Biodefense in China by Regions
2.3.1 Market Analysis of Biodefense in North China 2013-2017
2.3.2 Market Analysis of Biodefense in Northeast China 2013-2017
2.3.3 Market Analysis of Biodefense in East China 2013-2017
2.3.4 Market Analysis of Biodefense in Central & South China 2013-2017
2.3.5 Market Analysis of Biodefense in Southwest China 2013-2017
2.3.6 Market Analysis of Biodefense in Northwest China 2013-2017
2.4 Market Development Forecast of Biodefense in China 2018-2023
2.4.1 Market Development Forecast of Biodefense in China 2018-2023
2.4.2 Market Development Forecast of Biodefense by Regions 2018-2023
CHAPTER 3 CHINA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole China Market Status by Types
3.1.1 Consumption Volume of Biodefense in China by Types
3.1.2 Revenue of Biodefense in China by Types
3.2 China Market Status by Types in Major Countries
3.2.1 Market Status by Types in North China
3.2.2 Market Status by Types in Northeast China
3.2.3 Market Status by Types in East China
3.2.4 Market Status by Types in Central & South China
3.2.5 Market Status by Types in Southwest China
3.2.6 Market Status by Types in Northwest China
3.3 Market Forecast of Biodefense in China by Types
CHAPTER 4 CHINA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Biodefense in China by Downstream Industry
4.2 Demand Volume of Biodefense by Downstream Industry in Major Countries
4.2.1 Demand Volume of Biodefense by Downstream Industry in North China
4.2.2 Demand Volume of Biodefense by Downstream Industry in Northeast China
4.2.3 Demand Volume of Biodefense by Downstream Industry in East China
4.2.4 Demand Volume of Biodefense by Downstream Industry in Central & South China
4.2.5 Demand Volume of Biodefense by Downstream Industry in Southwest China
4.2.6 Demand Volume of Biodefense by Downstream Industry in Northwest China
4.3 Market Forecast of Biodefense in China by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIODEFENSE
5.1 China Economy Situation and Trend Overview
5.2 Biodefense Downstream Industry Situation and Trend Overview
CHAPTER 6 BIODEFENSE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN CHINA
6.1 Sales Volume of Biodefense in China by Major Players
6.2 Revenue of Biodefense in China by Major Players
6.3 Basic Information of Biodefense by Major Players
6.3.1 Headquarters Location and Established Time of Biodefense Major Players
6.3.2 Employees and Revenue Level of Biodefense Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BIODEFENSE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Emergent Biosolutions
7.1.1 Company profile
7.1.2 Representative Biodefense Product
7.1.3 Biodefense Sales, Revenue, Price and Gross Margin of Emergent Biosolutions
7.2 Hytest
7.2.1 Company profile
7.2.2 Representative Biodefense Product
7.2.3 Biodefense Sales, Revenue, Price and Gross Margin of Hytest
7.3 GSK
7.3.1 Company profile
7.3.2 Representative Biodefense Product
7.3.3 Biodefense Sales, Revenue, Price and Gross Margin of GSK
7.4 Sanofi
7.4.1 Company profile
7.4.2 Representative Biodefense Product
7.4.3 Biodefense Sales, Revenue, Price and Gross Margin of Sanofi
7.5 PharmAthene
7.5.1 Company profile
7.5.2 Representative Biodefense Product
7.5.3 Biodefense Sales, Revenue, Price and Gross Margin of PharmAthene
7.6 Bavarian Nordic
7.6.1 Company profile
7.6.2 Representative Biodefense Product
7.6.3 Biodefense Sales, Revenue, Price and Gross Margin of Bavarian Nordic
7.7 SIGA Technologies
7.7.1 Company profile
7.7.2 Representative Biodefense Product
7.7.3 Biodefense Sales, Revenue, Price and Gross Margin of SIGA Technologies
7.8 Arbutus Biopharma
7.8.1 Company profile
7.8.2 Representative Biodefense Product
7.8.3 Biodefense Sales, Revenue, Price and Gross Margin of Arbutus Biopharma
7.9 DynPort Vaccine
7.9.1 Company profile
7.9.2 Representative Biodefense Product
7.9.3 Biodefense Sales, Revenue, Price and Gross Margin of DynPort Vaccine
7.10 Xoma Corporation
7.10.1 Company profile
7.10.2 Representative Biodefense Product
7.10.3 Biodefense Sales, Revenue, Price and Gross Margin of Xoma Corporation
7.11 Ichor Medical Systems
7.11.1 Company profile
7.11.2 Representative Biodefense Product
7.11.3 Biodefense Sales, Revenue, Price and Gross Margin of Ichor Medical Systems
7.12 Aeolus Pharmaceuticals
7.12.1 Company profile
7.12.2 Representative Biodefense Product
7.12.3 Biodefense Sales, Revenue, Price and Gross Margin of Aeolus Pharmaceuticals
7.13 Achaogen
7.13.1 Company profile
7.13.2 Representative Biodefense Product
7.13.3 Biodefense Sales, Revenue, Price and Gross Margin of Achaogen
7.14 Elusys Therapeutics
7.14.1 Company profile
7.14.2 Representative Biodefense Product
7.14.3 Biodefense Sales, Revenue, Price and Gross Margin of Elusys Therapeutics
7.15 Dynavax Technologies
7.15.1 Company profile
7.15.2 Representative Biodefense Product
7.15.3 Biodefense Sales, Revenue, Price and Gross Margin of Dynavax Technologies
7.16 Cleveland BioLabs
7.17 Soligenix
7.18 Alnylam Pharmaceuticals
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIODEFENSE
8.1 Industry Chain of Biodefense
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIODEFENSE
9.1 Cost Structure Analysis of Biodefense
9.2 Raw Materials Cost Analysis of Biodefense
9.3 Labor Cost Analysis of Biodefense
9.4 Manufacturing Expenses Analysis of Biodefense
CHAPTER 10 MARKETING STATUS ANALYSIS OF BIODEFENSE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Biodefense in This Report
1.2 Commercial Types of Biodefense
1.2.1 Anthrax
1.2.2 Smallpox
1.2.3 Botulism
1.2.4 Radiation/Nuclear
1.3 Downstream Application of Biodefense
1.3.1 Industry
1.3.2 Chemical
1.4 Development History of Biodefense
1.5 Market Status and Trend of Biodefense 2013-2023
1.5.1 China Biodefense Market Status and Trend 2013-2023
1.5.2 Regional Biodefense Market Status and Trend 2013-2023
CHAPTER 2 CHINA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Biodefense in China 2013-2017
2.2 Consumption Market of Biodefense in China by Regions
2.2.1 Consumption Volume of Biodefense in China by Regions
2.2.2 Revenue of Biodefense in China by Regions
2.3 Market Analysis of Biodefense in China by Regions
2.3.1 Market Analysis of Biodefense in North China 2013-2017
2.3.2 Market Analysis of Biodefense in Northeast China 2013-2017
2.3.3 Market Analysis of Biodefense in East China 2013-2017
2.3.4 Market Analysis of Biodefense in Central & South China 2013-2017
2.3.5 Market Analysis of Biodefense in Southwest China 2013-2017
2.3.6 Market Analysis of Biodefense in Northwest China 2013-2017
2.4 Market Development Forecast of Biodefense in China 2018-2023
2.4.1 Market Development Forecast of Biodefense in China 2018-2023
2.4.2 Market Development Forecast of Biodefense by Regions 2018-2023
CHAPTER 3 CHINA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole China Market Status by Types
3.1.1 Consumption Volume of Biodefense in China by Types
3.1.2 Revenue of Biodefense in China by Types
3.2 China Market Status by Types in Major Countries
3.2.1 Market Status by Types in North China
3.2.2 Market Status by Types in Northeast China
3.2.3 Market Status by Types in East China
3.2.4 Market Status by Types in Central & South China
3.2.5 Market Status by Types in Southwest China
3.2.6 Market Status by Types in Northwest China
3.3 Market Forecast of Biodefense in China by Types
CHAPTER 4 CHINA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Biodefense in China by Downstream Industry
4.2 Demand Volume of Biodefense by Downstream Industry in Major Countries
4.2.1 Demand Volume of Biodefense by Downstream Industry in North China
4.2.2 Demand Volume of Biodefense by Downstream Industry in Northeast China
4.2.3 Demand Volume of Biodefense by Downstream Industry in East China
4.2.4 Demand Volume of Biodefense by Downstream Industry in Central & South China
4.2.5 Demand Volume of Biodefense by Downstream Industry in Southwest China
4.2.6 Demand Volume of Biodefense by Downstream Industry in Northwest China
4.3 Market Forecast of Biodefense in China by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIODEFENSE
5.1 China Economy Situation and Trend Overview
5.2 Biodefense Downstream Industry Situation and Trend Overview
CHAPTER 6 BIODEFENSE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN CHINA
6.1 Sales Volume of Biodefense in China by Major Players
6.2 Revenue of Biodefense in China by Major Players
6.3 Basic Information of Biodefense by Major Players
6.3.1 Headquarters Location and Established Time of Biodefense Major Players
6.3.2 Employees and Revenue Level of Biodefense Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BIODEFENSE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Emergent Biosolutions
7.1.1 Company profile
7.1.2 Representative Biodefense Product
7.1.3 Biodefense Sales, Revenue, Price and Gross Margin of Emergent Biosolutions
7.2 Hytest
7.2.1 Company profile
7.2.2 Representative Biodefense Product
7.2.3 Biodefense Sales, Revenue, Price and Gross Margin of Hytest
7.3 GSK
7.3.1 Company profile
7.3.2 Representative Biodefense Product
7.3.3 Biodefense Sales, Revenue, Price and Gross Margin of GSK
7.4 Sanofi
7.4.1 Company profile
7.4.2 Representative Biodefense Product
7.4.3 Biodefense Sales, Revenue, Price and Gross Margin of Sanofi
7.5 PharmAthene
7.5.1 Company profile
7.5.2 Representative Biodefense Product
7.5.3 Biodefense Sales, Revenue, Price and Gross Margin of PharmAthene
7.6 Bavarian Nordic
7.6.1 Company profile
7.6.2 Representative Biodefense Product
7.6.3 Biodefense Sales, Revenue, Price and Gross Margin of Bavarian Nordic
7.7 SIGA Technologies
7.7.1 Company profile
7.7.2 Representative Biodefense Product
7.7.3 Biodefense Sales, Revenue, Price and Gross Margin of SIGA Technologies
7.8 Arbutus Biopharma
7.8.1 Company profile
7.8.2 Representative Biodefense Product
7.8.3 Biodefense Sales, Revenue, Price and Gross Margin of Arbutus Biopharma
7.9 DynPort Vaccine
7.9.1 Company profile
7.9.2 Representative Biodefense Product
7.9.3 Biodefense Sales, Revenue, Price and Gross Margin of DynPort Vaccine
7.10 Xoma Corporation
7.10.1 Company profile
7.10.2 Representative Biodefense Product
7.10.3 Biodefense Sales, Revenue, Price and Gross Margin of Xoma Corporation
7.11 Ichor Medical Systems
7.11.1 Company profile
7.11.2 Representative Biodefense Product
7.11.3 Biodefense Sales, Revenue, Price and Gross Margin of Ichor Medical Systems
7.12 Aeolus Pharmaceuticals
7.12.1 Company profile
7.12.2 Representative Biodefense Product
7.12.3 Biodefense Sales, Revenue, Price and Gross Margin of Aeolus Pharmaceuticals
7.13 Achaogen
7.13.1 Company profile
7.13.2 Representative Biodefense Product
7.13.3 Biodefense Sales, Revenue, Price and Gross Margin of Achaogen
7.14 Elusys Therapeutics
7.14.1 Company profile
7.14.2 Representative Biodefense Product
7.14.3 Biodefense Sales, Revenue, Price and Gross Margin of Elusys Therapeutics
7.15 Dynavax Technologies
7.15.1 Company profile
7.15.2 Representative Biodefense Product
7.15.3 Biodefense Sales, Revenue, Price and Gross Margin of Dynavax Technologies
7.16 Cleveland BioLabs
7.17 Soligenix
7.18 Alnylam Pharmaceuticals
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIODEFENSE
8.1 Industry Chain of Biodefense
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIODEFENSE
9.1 Cost Structure Analysis of Biodefense
9.2 Raw Materials Cost Analysis of Biodefense
9.3 Labor Cost Analysis of Biodefense
9.4 Manufacturing Expenses Analysis of Biodefense
CHAPTER 10 MARKETING STATUS ANALYSIS OF BIODEFENSE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
